Role of type 1 diabetes- Associated snps on risk of autoantibody positivity in the TEDDY study

Diabetes

Volumn 64, Issue 5, 2015, Pages 1818-1829

  Törn, Carina ^a   Hadley, David ^b,c   Lee, Hye Seung ^b   Hagopian, William ^d   Lernmark, Åke ^a   Simell, Olli ^e   Rewers, Marian ^f   Ziegler, Anette ^g   Schatz, Desmond ^h   Akolkar, Beena ⁱ   Onengut Gumuscu, Suna ^j   Chen, Wei Min ^j   Toppari, Jorma ^e   Mykkänen, Juha ^e   Ilonen, Jorma ^e,k   Rich, Stephen S ^j   She, Jin Xiong ^l   Steck, Andrea K ^f   Krischer, Jeffrey ^b  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d PACIFIC NORTHWEST RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF TURKU   (Finland)

^f UNIVERSITY OF COLORADO DENVER   (United States)

^g INSTITUT FÜR DIABETESFORSCHUNG   (Germany)

^h UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

ⁱ NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^j UNIVERSITY OF VIRGINIA   (United States)

^k UNIVERSITY OF EASTERN FINLAND   (Finland)

^l MEDICAL COLLEGE OF GEORGIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE 65; IA 2A AUTOANTIBODY; MICRO INSULIN AUTOANTIBODY; UNCLASSIFIED DRUG; HLA ANTIGEN;

ARTICLE; BLOOD SAMPLING; CELL PROLIFERATION; CHILD; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; GENETIC RISK; GENOME-WIDE ASSOCIATION STUDY; GENOTYPING TECHNIQUE; HEREDITY; HLA SYSTEM; HLA TYPING; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NEWBORN; OLIGONUCLEOTIDE PROBE; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; AUTOIMMUNITY; BLOOD; CLINICAL TRIAL; EUROPE; GENETIC PREDISPOSITION; GENETICS; GENOME; GENOTYPE; IMMUNOLOGY; METABOLISM; MULTICENTER STUDY; PANCREAS ISLET; UNITED STATES;

AUTOANTIBODIES; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; EUROPE; GENETIC PREDISPOSITION TO DISEASE; GENOME; GENOTYPE; HLA ANTIGENS; HUMANS; INFANT, NEWBORN; ISLETS OF LANGERHANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; UNITED STATES;

EID: 84981556018     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-1497     Document Type: Article

References (40)

1. Lambert AP, Gillespie KM, Thomson G, et al. Absolute risk of childhoodonset type 1 diabetes defined by human leukocyte antigen class II genotype: A population-based study in the United Kingdom. J Clin Endocrinol Metab 2004; 89:4037-4043.
2. Kaprio J, Tuomilehto J, Koskenvuo M, et al. Concordance for type 1 (insulindependent) and type 2 (non-insulin-dependent) diabetes mellitus in a populationbased cohort of twins in Finland. Diabetologia 1992;35:1060-1067.
3. Redondo MJ, Jeffrey J, Fain PR, Eisenbarth GS, Orban T. Concordance for islet autoimmunity among monozygotic twins. N Engl J Med 2008;359:2849-2850.
4. Barrett JC, Clayton DG, Concannon P, et al.; Type 1 Diabetes Genetics Consortium. Genome-wide association study and meta- Analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009;41:703-707.
5. Cooper JD, Howson JM, Smyth D, et al.; Type 1 Diabetes Genetics Consortium. Confirmation of novel type 1 diabetes risk loci in families. Diabetologia 2012;55:996-1000.
6. Achenbach P, Hummel M, Thümer L, Boerschmann H, Höfelmann D, Ziegler AG. Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children. Diabetologia 2013;56:1615-1622.
7. Steck AK, Wong R, Wagner B, et al. Effects of non-HLA gene polymorphisms on development of islet autoimmunity and type 1 diabetes in a population with high-risk HLA-DR, DQ genotypes. Diabetes 2012;61:753-758.
8. Frederiksen BN, Steck AK, Kroehl M, Lamb MM, Wong R, Rewers M, Norris JM. Evidence of stage- And age-related heterogeneity of non-HLA SNPs and risk of islet autoimmunity and type 1 diabetes: The Diabetes Autoimmunity Study in the Young. Clin Dev Immunol 2013;2013:417657.
9. Orban T, Sosenko JM, Cuthbertson D, et al.; Diabetes Prevention Trial-Type 1 Study Group. Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1. Diabetes Care 2009;32:2269-2274.
10. Sosenko JM, Krischer JP, Palmer JP, et al.; Diabetes Prevention Trial-Type 1 Study Group. A risk score for type 1 diabetes derived from autoantibodypositive participants in the diabetes prevention trial- Type 1. Diabetes Care 2008; 31:528-533.
11. Gepts W, Lecompte PM. The pancreatic islets in diabetes. Am J Med 1981; 70:105-115.
12. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33(Suppl. 1):S62-S69.
13. TEDDY Study Group. The Environmental Determinants of Diabetes in the Young (TEDDY) study: study design. Pediatr Diabetes 2007;8:286-298.
14. Hagopian WA, Erlich H, Lernmark A, et al.; TEDDY Study Group. The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants. Pediatr Diabetes 2011; 12:733-743.
15. Bonifacio E, Yu L, Williams AK, et al. Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for National Institute of Diabetes and Digestive and Kidney Diseases consortia. J Clin Endocrinol Metab 2010;95:3360-3367.
16. Babaya N, Yu L, Miao D, et al. Comparison of insulin autoantibody: polyethylene glycol and micro-IAA 1-day and 7-day assays. Diabetes Metab Res Rev 2009;25:665-670.
17. Törn C, Mueller PW, Schlosser M, Bonifacio E, Bingley PJ; Participating Laboratories. Diabetes Antibody Standardization Program: Evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2. Diabetologia 2008;51:846-852.
18. Schlosser M, Mueller PW, Törn C, Bonifacio E, Bingley PJ; Participating Laboratories. Diabetes Antibody Standardization Program: Evaluation of assays for insulin autoantibodies. Diabetologia 2010;53:2611-2620.
19. Dantonio P, Meredith-Molloy N, Hagopian WA, et al. Proficiency testing of human leukocyte antigen-DR and human leukocyte antigen-DQ genetic risk assessment for type 1 diabetes using dried blood spots. J Diabetes Sci Tech 2010;4:929-941.
20. Concannon P, Chen WM, Julier C, et al.; Type 1 Diabetes Genetics Consortium. Genome-wide scan for linkage to type 1 diabetes in 2, 496 multiplex families from the Type 1 Diabetes Genetics Consortium. Diabetes 2009;58:1018-1022.
21. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006;38:904-909.
22. Purcell S, Neale B, Todd-Brown K, et al. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81: 559-575.
23. Smyth DJ, Plagnol V, Walker NM, et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 2008;359:2767-2777.
24. Reddy MV, Wang H, Liu S, et al. Association between type 1 diabetes and GWAS SNPs in the southeast US Caucasian population. Genes Immun 2011;12: 208-212.
25. Plagnol V, Howson JM, Smyth DJ, et al.; Type 1 Diabetes Genetics Consortium. Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases. PLoS Genet 2011;7:e1002216.
26. Gianchecchi E, Palombi M, Fierabracci A. The putative role of the C1858T polymorphism of protein tyrosine phosphatase PTPN22 gene in autoimmunity. Autoimmun Rev 2013;12:717-725.
27. Lempainen J, Hermann R, Veijola R, Simell O, Knip M, Ilonen J. Effect of the PTPN22 and INS risk genotypes on the progression to clinical type 1 diabetes after the initiation of β-cell autoimmunity. Diabetes 2012;61:963-966.
28. Bottini N, Musumeci L, Alonso A, et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004;36:337- 338.
29. Kyogoku C, Langefeld CD, Ortmann WA, et al. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 2004;75:504-507.
30. Begovich AB, Carlton VE, Honigberg LA, et al. A missense singlenucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004;75: 330-337.
31. Lempainen J, Vaarala O, Mäkelä M, et al. Interplay between PTPN22 C1858T polymorphism and cow's milk formula exposure in type 1 diabetes. J Autoimmun 2009;33:155-164.
32. Maziarz M, Janer M, Roach JC, et al.; Swedish Childhood Diabetes Register; Diabetes Incidence in Sweden Study Group. The association between the PTPN22 1858C.T variant and type 1 diabetes depends on HLA risk and GAD65 autoantibodies. Genes Immun 2010;11:406-415.
33. Bose R, Zhang X. The ErbB kinase domain: structural perspectives into kinase activation and inhibition. Exp Cell Res 2009;315:649-658.
34. Devallière J, Charreau B. The adaptor Lnk (SH2B3): An emerging regulator in vascular cells and a link between immune and inflammatory signaling. Biochem Pharmacol 2011;82:1391-1402.
35. Zhernakova A, Elbers CC, Ferwerda B, et al.; Finnish Celiac Disease Study Group. Evolutionary and functional analysis of celiac risk loci reveals SH2B3 as a protective factor against bacterial infection. Am J Hum Genet 2010;86:970-977.
36. Vu-Hong TA, Durand E, Deghmoun S, et al. The INS VNTR locus does not associate with smallness for gestational age (SGA) but interacts with SGA to increase insulin resistance in young adults. J Clin Endocrinol Metab 2006;91: 2437-2440.
37. Bennett ST, Wilson AJ, Cucca F, et al. IDDM2-VNTR-encoded susceptibility to type 1 diabetes: dominant protection and parental transmission of alleles of the insulin gene-linked minisatellite locus. J Autoimmun 1996;9:415-421.
38. Barratt BJ, Payne F, Lowe CE, et al. Remapping the insulin gene/IDDM2 locus in type 1 diabetes. Diabetes 2004;53:1884-1889.
39. Walter M, Albert E, Conrad M, et al. IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of Type 1 diabetes and associated autoimmunity. Diabetologia 2003;46:712-720.
40. Bonifacio E, Krumsiek J, Winkler C, Theis FJ, Ziegler AG. A strategy to find gene combinations that identify children who progress rapidly to type 1 diabetes after islet autoantibody seroconversion. Acta Diabetol 2014;51:403-411.